Comments
Divi’s Laboratories on Friday said its Vishakhapatnam facility has successfully completed inspection by the health product regulators of Ireland and Slovenia without any critical observations. In a notice to the exchanges, the company said Unit-2 at Vishakhapatnam had been inspected by five inspectors from Health Products Regulatory Authority (HPRA) of Ireland and Agency for Medicinal Products and Medical Devices of the Republic of Slovenia from July 31 to August 4, 2017. The inspection was focused on follow-up of the effectiveness of the corrective and preventive actions (CAPAs) implemented from the last JAZMP inspection, it added. The inspectors also focused on the general GMP inspection of the site, Divi’s Laboratories said. The inspection has concluded successfully with no critical observations being made, it added. Shares of Divi’s Laboratories closed at ₹682.15 on the NSE, up 1.82 per cent over the previous day’s close.
Vimal Oil & Foods has informed the exchanges that it has received a request from Vimal Dairy to re-classify its shareholding from the promoter group category to the public category. According to information available with the exchanges, Vimal Dairy currently holds 2.2 lakh shares, which is 1.46 per cent of the equity base of the company. Shares of Vimal Oil, after touching a year-low of ₹17.5, recovered to close flat at ₹18.10 on the NSE.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.